Checkmate Pharma Names Kleem Chaudhary Chief Business Officer

Xconomy Boston — 

Kleem Chaudhary has been appointed chief business officer of Cambridge, MA-based Checkmate Pharmaceuticals. He was most recently head of business development & licensing at Biogen (NASDAQ: BIIB). Chaudhary’s experience also includes positions at Takeda Pharmaceutical (NYSE: TAK) and Novartis (NYSE: NVS). Checkmate’s lead drug CMP-001, a type of cancer drug called an oligonucleotide, is in early-stage testing in multiple solid tumors.